Researchers: New method needed in dengue vaccine development

04/16/2013 | Yahoo

Researchers from the La Jolla Institute for Allergy and Immunology have found that, contrary to common belief, T cells actually are part of a mechanism to control dengue virus infection. "The current thinking in the field is that the goal of a dengue vaccine should be the induction of antibodies and not T cells. But our results suggest that both cell types are needed to produce a strong immune response against dengue infection," said scientist Alessandro Sette. The finding, published in the journal Proceedings of the National Academy of Sciences, suggests that a new approach to dengue vaccine development may be needed.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC